Form 8-K - Current report:
SEC Accession No. 0001564590-17-012062
Filing Date
2017-06-02
Accepted
2017-06-02 16:45:35
Documents
2
Period of Report
2017-06-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20170602.htm 8-K 70945
2 EX-3.1 dvax-ex31_6.htm EX-3.1 9684
  Complete submission text file 0001564590-17-012062.txt   82026
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 17888639
SIC: 2834 Pharmaceutical Preparations